Janney Montgomery Scott LLC Cuts Stock Position in Cigna Group $CI

Janney Montgomery Scott LLC lessened its holdings in Cigna Group (NYSE:CI) by 21.5% in the first quarter, Holdings Channel reports. The firm owned 34,585 shares of the health services provider’s stock after selling 9,464 shares during the period. Janney Montgomery Scott LLC’s holdings in Cigna Group were worth $9,226,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Norges Bank purchased a new position in shares of Cigna Group in the 4th quarter worth about $1,019,790,000. Northwestern Mutual Wealth Management Co. increased its holdings in Cigna Group by 13,333.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock worth $900,912,000 after buying an additional 3,141,844 shares during the last quarter. Capital Research Global Investors raised its position in Cigna Group by 140.2% in the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after acquiring an additional 1,855,897 shares during the period. Dodge & Cox boosted its stake in Cigna Group by 19.7% in the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after acquiring an additional 1,833,389 shares during the last quarter. Finally, Boston Partners grew its position in shares of Cigna Group by 314.6% during the 4th quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock valued at $450,856,000 after acquiring an additional 1,243,056 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by insiders.

Cigna Group Price Performance

Shares of NYSE CI opened at $287.50 on Friday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $323.10. The stock has a market cap of $76.05 billion, a PE ratio of 12.19, a price-to-earnings-growth ratio of 1.07 and a beta of 0.29. The stock has a fifty day moving average of $284.84 and a 200-day moving average of $279.18.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter in the prior year, the firm posted $6.74 EPS. The firm’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were paid a dividend of $1.56 per share. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is currently 26.45%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Morgan Stanley lifted their price target on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and decreased their target price for the stock from $303.00 to $302.00 in a research report on Wednesday, May 20th. Mizuho upped their price target on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Finally, Jefferies Financial Group dropped their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $338.30.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.